SHELFCRITTER AI Digest

COMPANY

Glean

companytopic-noteenterprise-ai

Overview

Glean is an enterprise AI-native search and work-assistant platform positioned in the horizontal enterprise-search / knowledge-work agent tier. In July 2026 it surfaces in the AI Digest corpus as one of three cohort-leader revenue-cadence data points — alongside Anthropic ($47B late-May run rate) and Sierra (second $100M ARR in two quarters) — that push on the “compounding faster at the top of the enterprise-AI stack” framing while MIT-reported broad-market GenAI pilots still show ~95% no measurable profit impact.

Timeline

  • 2026-07-09-AI-Digest — Glean crossed $300M ARR in May 2026, having crossed $200M in December 2025 — the $200M → $300M leg took six months against a prior nine months for $100M → $200M. TechCrunch’s Wednesday revenue-cadence piece surfaces the datapoint alongside Anthropic‘s $47B late-May run rate (up from $30B in April) and Sierra‘s second $100M in ARR in two quarters (after seven quarters for the first). Narrow read: three cohort-leader data points do not carry a broad-market claim on their own — MIT’s July report cited in EmTech coverage still shows ~95% of GenAI pilots with no measurable profit impact. Structural read worth carrying: the leaders-versus-market bifurcation is now sharp enough to matter for how the “AI revenue” story gets told in Q3 — Glean compressing the $100M-increment interval from nine months to six is a genuinely new datapoint at the horizontal-enterprise-search tier, but so is the fact that broad-market GenAI pilots are still showing thin profit impact. Carry both, not just the compounding side. Glean sits alongside Sierra as a vendor-platform-side leader while Anthropic is the lab-side leader — three distinct segments of the enterprise-AI stack all posting compounding leader-tier prints in the same window.

Key Developments

  1. $100M-Increment Interval Compression (May 2026): Nine months to go from $100M → $200M ARR compressed to six months for $200M → $300M is the load-bearing cadence signal — not the absolute number, but the acceleration inside the $100M-increment measurement. Puts Glean on a leader-tier compounding curve at the horizontal-enterprise-search tier.

  2. One of Three Cohort-Leader Prints Anchoring the “Compounding Faster” Framing: Landed alongside Anthropic $47B late-May run rate (+$17B vs April) and Sierra second $100M ARR in two quarters (vs seven for the first) — three data points from three different segments (lab / vendor-platform / horizontal-enterprise-search) that push on the same “compounding faster at the top of the stack” framing while broad-market MIT pilots still show ~95% no measurable profit impact. The bifurcation reads as strengthening rather than converging.

See also: Anthropic, Sierra, MIT Technology Review, MOC - Major Companies.